Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection Application for Permit To Export Controlled Substances, Application for Permit To Export Controlled Substances for Subsequent Reexport-DEA Forms 161, 161R, 53163-53164 [2016-19090]

Download as PDF Federal Register / Vol. 81, No. 155 / Thursday, August 11, 2016 / Notices CA, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership. On November 13, 2015, NCBDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513). notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on November 14, 2014 (79 FR 68301). The last notification was filed with the Department on May 2, 2016. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on May 24, 2016 (81 FR 32776). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2016–19039 Filed 8–10–16; 8:45 am] BILLING CODE P Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. DEPARTMENT OF JUSTICE [FR Doc. 2016–19035 Filed 8–10–16; 8:45 am] Antitrust Division BILLING CODE 4410–11–P Antitrust Division sradovich on DSK3GMQ082PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—Open Platform for NFV Project, Inc. Notice is hereby given that, on July 20, 2016, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Open Platform for NFV Project, Inc. (‘‘Open Platform for NFV Project’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Beijing Internet Institute, Beijing, PEOPLE’S REPUBLIC OF CHINA; Lenovo US, Morrisville, NC; and Qualcomm Technologies Inc., San Diego, CA, have been added as parties to this venture. Also, Ixia, Calabasas, CA, has withdrawn as a party to this venture. In addition, Freescale Semiconductor, Inc., has changed its name to NXP Semiconductors, Austin, TX. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Open Platform for NFV Project intends to file additional written notifications disclosing all changes in membership. On October 17, 2014, Open Platform for NFV Project filed its original VerDate Sep<11>2014 17:44 Aug 10, 2016 Jkt 238001 Notice is hereby given that, on July 14, 2016, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), ODPi, Inc. (‘‘ODPi’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Splunk Inc., San Francisco, CA; and 4C Decision, Herndon, VA, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and ODPi intends to file additional written notifications disclosing all changes in membership. On November 23, 2015, ODPi filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on December 23, 2015 (80 FR 79930). The last notification was filed with the Department on April 29, 2016. A notice was published in the Federal Register pursuant to Section 6(h) of the Act on May 24, 2016 (81 FR 32777). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2016–19036 Filed 8–10–16; 8:45 am] BILLING CODE 4410–11–P PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE [OMB Number 1117–0004] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection Application for Permit To Export Controlled Substances, Application for Permit To Export Controlled Substances for Subsequent Reexport—DEA Forms 161, 161R Drug Enforcement Administration, Department of Justice ACTION: 30-day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register at 81 FR 38220, June 13, 2016, allowing for a 60 day comment period. DATES: Comments are encouraged and will be accepted for an additional 30 days until September 12, 2016. FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Michael J. Lewis, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812 or sent to OIRA_submissions@ omb.eop.gov. SUMMARY: Notice Pursuant to the National Cooperative Research and Production Act of 1993—ODPI, Inc. DEPARTMENT OF JUSTICE 53163 Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the SUPPLEMENTARY INFORMATION: E:\FR\FM\11AUN1.SGM 11AUN1 53164 Federal Register / Vol. 81, No. 155 / Thursday, August 11, 2016 / Notices information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC 20530. Dated: August 8, 2016. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2016–19090 Filed 8–10–16; 8:45 am] BILLING CODE 4410–09–P sradovich on DSK3GMQ082PROD with NOTICES Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Application for Permit to Export Controlled Substances; Application for Permit to Export Controlled Substances for Subsequent Reexport. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Forms: 161, 161R. The applicable component within the Department of Justice is the Drug Enforcement Administration, Office of Diversion Control. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): None. Abstract: Title 21, Code of Federal Regulations (21 CFR), Sections 1312.21 and 1312.22 require that any person who desires to export or reexport controlled substances listed in schedules I or II, any narcotic substance listed in schedules III or IV, or any nonnarcotic substance in schedule III which the Administrator has specifically designated by regulation in § 1312.30, or any non-narcotic substance in schedule IV or V which is also listed in schedule I or II of the Convention on Psychotropic Substances, must have an export permit. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates that 134 respondents, with 6,116 responses annually to this collection. The DEA estimates that it takes .5 hour to complete the form. 6. An estimate of the total public burden (in hours) associated with the proposed collection: The DEA estimates that this collection takes 3,301 annual burden hours. If additional information is required please contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice VerDate Sep<11>2014 17:44 Aug 10, 2016 Jkt 238001 DEPARTMENT OF JUSTICE [OMB Number 1117–0023] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection Import/Export Declaration for List I and List II Chemicals—DEA Forms 486, 486A Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register at 81 FR 38218, June 13, 2016, allowing for a 60 day comment period. DATES: Comments are encouraged and will be accepted for an additional 30 days until September 12, 2016. FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Michael J. Lewis, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812 or sent to OIRA_submissions@ omb.eop.gov. SUMMARY: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the SUPPLEMENTARY INFORMATION: PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this information collection: 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Import/Export Declaration for List I and List II Chemicals. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Forms: 486, 486A. The applicable component within the Department of Justice is the Drug Enforcement Administration, Office of Diversion Control. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): None. Abstract: Section 1018 of the Controlled Substances Import and Export Act (CSIEA) (21 U.S.C. 971) and Title 21 Code of Federal Regulations (21 CFR) part 1313 require any persons who import, export, or conduct international transactions involving list I and list II chemicals are required to establish a system of recordkeeping and report certain information regarding those transactions to the DEA. The chemicals subject to control are used in the clandestine manufacture of controlled substances. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The below table presents information regarding the number of respondents, responses and associated burden hours. E:\FR\FM\11AUN1.SGM 11AUN1

Agencies

Department of Justice

[Federal Register Volume 81, Number 155 (Thursday, August 11, 2016)]
[Notices]
[Pages 53163-53164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19090]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0004]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Extension Without Change of a Previously Approved 
Collection Application for Permit To Export Controlled Substances, 
Application for Permit To Export Controlled Substances for Subsequent 
Reexport--DEA Forms 161, 161R

AGENCY: Drug Enforcement Administration, Department of Justice

ACTION: 30-day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995. This proposed information collection was previously published in 
the Federal Register at 81 FR 38220, June 13, 2016, allowing for a 60 
day comment period.

DATES: Comments are encouraged and will be accepted for an additional 
30 days until September 12, 2016.

FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated 
public burden or associated response time, suggestions, or need a copy 
of the proposed information collection instrument with instructions or 
additional information, please contact Michael J. Lewis, Office of 
Diversion Control, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 
598-6812 or sent to OIRA_submissions@omb.eop.gov.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the

[[Page 53164]]

information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other forms of information technology, e.g., 
permitting electronic submission of responses.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Application for Permit to Export 
Controlled Substances; Application for Permit to Export Controlled 
Substances for Subsequent Reexport.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: DEA Forms: 161, 161R. The 
applicable component within the Department of Justice is the Drug 
Enforcement Administration, Office of Diversion Control.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): None.
    Abstract: Title 21, Code of Federal Regulations (21 CFR), Sections 
1312.21 and 1312.22 require that any person who desires to export or 
reexport controlled substances listed in schedules I or II, any 
narcotic substance listed in schedules III or IV, or any non-narcotic 
substance in schedule III which the Administrator has specifically 
designated by regulation in Sec.  1312.30, or any non-narcotic 
substance in schedule IV or V which is also listed in schedule I or II 
of the Convention on Psychotropic Substances, must have an export 
permit.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 134 respondents, with 6,116 responses annually to this collection. 
The DEA estimates that it takes .5 hour to complete the form.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates that this collection 
takes 3,301 annual burden hours.
    If additional information is required please contact: Jerri Murray, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC 
20530.

    Dated: August 8, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-19090 Filed 8-10-16; 8:45 am]
 BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.